Page 386, Table I , 'ADHD-RS-IV score change and response rate' section, 'Response rate' subsection, 'GXR 0.075-0.09 mg/kg/day' row: The cell entry in the '95% Confidence interval' column, which previously read: ''63.3, 90.3'' should read: ''63.3, 90.9'' Page 387, Table I , 'Weekly rate of treatment discontinuation during maintenance (assuming constant hazard)' section, 'GXR' row: The first line of the cell entry in the 'Source' column, which previously read: ''Biederman et al., [9] 2008; Sallee et al., [10] 2009'' should read:
''Biederman et al., [35] 2008; Sallee et al., [36] 2009''
Page 387, Table I , 'Drug cost' section, 'ATX' subsection, 'Unit cost (cost per pill)' row: The third line of the cell entry in the 'Source' column, which previously read: ''(data on file, Shire Pharmaceuticals, Inc. [33] )'' should read:
''(data on file, Shire Development LLC [37] )'' Page 390, Table III Table III , 'Baseline outcomes, mean (SD)' section, 'Hyperactivity/impulsivity subscale score' row:
The cell entries in columns 3, 5, 7 and 8, which previously read: ''22.2 (7.1)'' should read:
''16.9 (7.1)''
Page 390, Table III , 'Baseline outcomes, mean (SD)' section, 'Inattention subscale score' row and 'Hyperactivity/impulsivity' row: The cell entries in columns 2, 4 and 6 of these two rows, which previously included asterisks, should not have had any asterisks (because the comparisons were not significant).
